The Summary
This comprehensive scientific review examines the bidirectional relationship between estrogen and the gut microbiome, known as the estrobolome, during menopause. Researchers analyzed current literature on how microbial diversity affects estrogen regulation and systemic inflammation. While geographic differences prevent a single ideal microbiome profile, findings show that higher microbial diversity correlates with better estrogen regulation, whereas reduced diversity links to inflammation and worse symptoms. The authors highlight diet, phytoestrogens, and targeted probiotics as promising, non-hormonal adjuvant therapies to complement standard hormone replacement therapy.
Why this is interesting
For decades, menopause was viewed strictly as an ovarian decline, treatable primarily with hormone replacement therapy. However, this review reveals that our gut microbes actively help regulate estrogen levels. By identifying the estrobolome as a key player in hormonal health, this research shifts the focus toward personalized, dietary interventions. For women transitioning through menopause, this means lifestyle choices—like eating prebiotic-rich foods and taking strain-specific probiotics—could offer accessible, non-hormonal ways to manage symptoms, reduce inflammation, and take greater agency over their health transitions.